Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001432453-15-000019)

Filing Details

Accession Number:: 0001432453-15-000019
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2015-03-10 15:30:28
Reporting Period:: 2014-01-31

Filing Date:: 2015-03-10
Accepted Time:: 2015-03-10 15:30:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1464165	Neurokine Pharmaceuticals Inc.	NEUKF	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1464116	Ahmad Doroudian	1275 West 6Th Avenue Vancouver A1 V6H 1A6	Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2013-09-24	35,000,000	$0.00	37,469,784	No	5	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares	2,469,784	Direct
Common Shares	2,000,000	Indirect	owned by spouse
Common Shares	2,000,000	Indirect	owned by Kinwa Pharma International Company Ltd.

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Stock Options	$0.01	2010-05-25	2015-05-25	800,000	800,000	Direct
Common Shares	Warrants	$0.01	2010-07-30	2015-07-29	500,000	500,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-05-25	800,000	800,000	Direct
2015-07-29	500,000	500,000	Direct

Footnotes

Kinwa Pharma International Company Ltd. is a company over which Dr. Ahmad Doroudian and his spouse have shared voting and investment power.
Acquisition of shares through settlement of debts (deemed price of $0.001)